Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs
Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”
Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.
The cost of CAR-T in Thailand is USD 150000 - USD 470000
Additionally, factors like the duration of treatment, the need for follow-up care, and the use of advanced technologies or specialized treatments can further influence the overall cost.
CART is an acronym for a promising experimental type of cancer treatment called Chimeric Antigen Receptor T-cell therapy and mainly targets blood malignancies such as leukemia and lymphoma. This therapy is done by modifying the patient’s T-cells (one form of white blood cells) in the laboratory and making them have a receptor that homes in on cancerous cells. These engineered T-cells are then transduced back into the patient, they go on to hunt for cancer cells to kill.
CART therapy is rather effective, particularly in the cases of the treatment efficacy of which has not been rather impressive. It is individual treatment, which means that is independent of the cancer type in the patient. There are risks for cytokine release syndrome (CRS), as well as neurotoxicity that should be closely watched out for, but this option is hopeful for cancer patients who normally cannot be treated with conventional treatments.
| City | Cost (USD) | |
|---|---|---|
| Bangkok | $150,000 – $470,000 | Explore More |
Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.
With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.
Readers can explore her published research and articles here:
Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
CAR T cell therapy is classified as follows:
Antigen-based classification: It includes
CAR T-cell therapy is primarily used to treat blood cancers, such as multiple myeloma, large B-cell lymphoma, and B-cell acute lymphoblastic leukaemia. The patient's own T cells are reprogrammed to identify and destroy cancer cells, cause remission, enhance survival, and have a plan B in case other treatments fail.
Patients with blood cancers who relapsed or are refractory must consult an oncologist to determine candidacy for CAR T therapy, especially if they have failed to respond to traditional treatments (i.e., chemotherapy, radiation, or stem cell transplant). Evaluation is warranted for symptoms such as loss of weight, swelling of lymph nodes, recurrent infection, chronic fatigue, or spontaneous bruising.
Screening tests consist of imaging, bone marrow biopsy, and blood work.
Leukapheresis is utilised to harvest T cells from the patient's blood for T-cell collection.
Bridging therapy: Certain patients receive chemotherapy while waiting for CAR T cells to be produced.
Lymphodepleting chemotherapy is administered before the injection to make room for CAR T cells. The patients should plan for potential hospitalisation, designate caretakers, and discuss long-term follow-up and expected adverse effects with the medical team.
The whole process, from cell harvesting to infusion, can take three to six weeks. The infusion itself takes a few hours to a few minutes, but for at least one week following the infusion, close monitoring is required, and there will be frequent follow-ups for several months.
One of the newer treatment options for some blood cancers is CAR T-cell therapy. It is utilised when other treatments are not working or the cancer recurs. CAR T-cell therapy has the potential to cure many blood cancers and extend life in most cases.
Recovery involves managing side effects like CRS and neurotoxicity, monitoring blood levels, and avoiding infections. Laboratory testing, imaging, and monitoring for late issues like hypogammaglobulinemia or relapse are all included in long-term follow-up.
The nature of the cancer, the burden of the disease, and an individual's response all impact success. For example, in pediatric acute lymphoblastic leukaemia, complete remission rates are more than 80%. However, relapse is always a risk, and long-term success is variable.
Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.
✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours
Your medical info has is HIPAA-style confidential. We never share with hospitals without your consent.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Hendrik decided to come to India for his treatment after a thorough discussion with MediGence. India is known for its…
A. CAR-T cost in Thailand varies from one hospital to the other. The cost quoted by some of the best hospitals for CAR-T in Thailand generally covers the pre-surgery investigations of the patient. The treatment cost usually includes the expenses related to hospitalization, surgery, nursing, medicines, and anesthesia. Extended hospital stay, complications after the surgery, or new diagnosis may affect the overall cost of CAR-T in Thailand.
Many hospitals across the country offer CAR-T to international patients. Some of the most renowned hospitals for CAR-T in Thailand include the following:
A. After discharge from the hospital, the patient has to stay for another 30 days in the country for complete recovery. During this time, the patient undergoes medical tests and consultations. this is to ensure that the treatment was successful and the patient is safe to return.
The length of recovery following CAR-T cell therapy varies based on a patient's unique circumstances, such as their general health and treatment response. Patients may need to stay in the hospital for monitoring for a maximum of seven to fourteen days, while some may need longer.
It may take from weeks to months for a patient to fully recover, and others may require continuous care due to adverse effects. Although the procedure might be comparable in Thailand, it's essential to speak with a local healthcare professional for advice tailored to your particular situation.
A. There are certain additional costs that the patient has to pay apart from the CAR-T cost. The per day cost in this case may start from USD 50 per person.
A. Some of the popular cities in Thailand that offer CAR-T include the following:
A. Patients who are interested in availing of telemedicine consultation before they travel for CAR-T in Thailand can opt for the same. Many CAR-T surgeons offer video telemedicine consultation, including the following:
| Doctor | Cost | Schedule Your Appointment |
|---|---|---|
| Dr. Saipin Tangkaratt | USD 130 | Schedule Now |
| Dr. Suchart Chaimuangraj | USD 81 | Schedule Now |
| Dr. Voratape Kijtavee | USD 81 | Schedule Now |
After CAR-T, the patient is supposed to stay for about 2 days in the hospital for recovery and monitoring. The patient is subjected to several biochemistry and radiological scans to see that everything is okay and the recovery is on track. After making sure that the patient is clinically stable, discharge is planned.
A. There are more than 1 hospitals that offer CAR-T in Thailand. These clinics have propoer infrastructure as well as offer good quality services when it comes to CAR-T These hospitals comply with all the rules and regulations as dictated by the regulatory bodies and medical associations in Thailand
A. Some of the renowned doctors for CAR-T in Thailand are:
A. CAR-T's success rate in Thailand depends on factors such as the patient population and substance use. CAR-T therapy has remarkable results, specifically for hematological malignancies such as Acute Lymphoblastic Leukemia (ALL) and a few types of lymphoma.
The CAR-T response can vary between forty to eighty percent in a clinical setting which is dependent on the. This therapy is relatively novel and evolving and has not been publicized yet. It is advised to consult a healthcare professional before undergoing CAR-T.
A. Yes, international patients may be eligible for CAR-T treatment in Thailand. CAR-T treatment can be obtained throughout Thailand at several healthcare facilities that are ready to treat foreign patients. Such clinics can offer assistance when it comes to transportation, accommodation, and further management and, usually, might have experience working with foreigners.
If one is to consider this particular approach then one should contact the specific medical facility to find out their procedures, qualification criteria, and any fees associated with the process.
Specifically designed for blood cancer, AR T-cell therapy is a tailored cancer treatment modality. Blood from the patient will be used to create T-cells that will be transformed into chimeric antigen receptors (CAR) in a lab. T-cells can identify a particular kind of malignancy because of their modified antigen receptors.
Upon being reintroduced into the cancer patient's body, CAR T-cells will eradicate the specific cancer cells. Additionally, CAR T-cells will steadily multiply, remain in the body, suppress cancer cells, and stop cancer from returning.
CAR-T cells can be used to treat the following:
A. Some patients may need CAR T-cell therapy since their childhood cancer has relapsed. It can also be applied in managing refractory (R/R) blood malignancies that do not respond to conventional therapies; such as acute lymphoblastic leukemia (ALL), Large B cell non-Hodgkin’s lymphoma, and solid tumors- neuroblastoma.
It may be helpful to talk to a pediatric oncologist who will assess whether or not you are suitable for CAR T-cell therapy due to your state of health. These include the type of cancer, the stage of the cancer, the previous treatments that have been given, and overall health. One should contact a pediatric oncologist for consultation and recommendations.
A. CAR T-cell treatment is referred to as "living medications." As the name suggests, T cells are the foundation of CAR T-cell treatment since they assist in coordinating the immune system's response and eliminating pathogen-infected cells. The CAR T-cell treatments that are now available are personalized for each patient.
A. Yes, clinical studies utilizing CAR-T treatment are accessible in Thailand. Numerous medical facilities and academic establishments across the nation are engaged in continuous investigations aimed at assessing the effectiveness and safety of CAR-T therapies for various cancer types.
A. While CAR T-cell therapy has demonstrated remarkable efficacy in treating certain tumors that are difficult to treat, it can occasionally result in severe or even fatal side effects.
The following are other major negative effects of CAR T-cell treatment that may occur:
A. Yes, a customized treatment plan is usually involved with CAR-T therapy in Thailand. The procedure is customized for each patient and consists of the following:
The goal of this individualized strategy is to improve patient outcomes and therapy efficacy. Talking through these details with your medical team will help you better understand how CAR-T therapy will be customized for you.
A. Indeed, depending on the individual circumstances of the patient and the type of cancer being treated, CAR-T therapy can be used in combination with other cancer treatments in Thailand. Common combinations could consist of:
Always speak with your medical team to determine the best course of action for your particular illness. They can shed light on the advantages and disadvantages of combining different therapies.
Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.
Upload Your Reports
